Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pseudoephedrine ergogenic effects on endurance performance and urine/blood threshold determination
2024-513810-36-00Phase 4Completed
- Sponsor
- Ghent University
- Start
- Aug 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of naphazoline + chlorphenamine (3 arms), sponsored by Ghent University. Primary endpoint: Change in time trial duration and average power output: placebo vs 240 mg pseudoephedrine. Started Aug 2025; status: completed.
02
Drugs
naphazoline + chlorphenamine
Beyond the preview
Go deeper on 2024-513810-36-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-513810-36-00.